Document is current
Any future updates will be listed below
-
Authors
Furer, N.
Rappoport, N.
Milman, O. https://orcid.org/0000-0001-8957-4964
Tavor, S.
Lifshitz, A. https://orcid.org/0000-0002-8458-9507
Bercovich, A. https://orcid.org/0000-0002-2883-2306
Ben-Kiki, O.
Danin, A.
Kedmi, M.
Shipony, Z.
Lipson, D.
Meiri, E.
Yanai, G.
Shapira, S.
Arber, N.
Berdichevsky, S.
Tyner, J. https://orcid.org/0000-0002-2133-0960
Joshi, S. https://orcid.org/0000-0003-2798-5762
Landau, D. https://orcid.org/0000-0003-2346-9541
Ganesan, S.
Dusaj, N. https://orcid.org/0000-0002-4357-312X
Chamely, P.
Kaushansky, N.
Chapal-Ilani, N.
Shamir, R. https://orcid.org/0000-0003-1889-9870
Tanay, A. https://orcid.org/0000-0001-9419-3824
Shlush, L. https://orcid.org/0000-0002-3700-270X
- License Information
-
More Information
Article History
Received: 1 May 2024
Accepted: 11 April 2025
First Online: 27 June 2025
Competing interests
: Z.S., D.L., E.M. and G.Y. are all employees and shareholders of Ultima Genomics. L.S. is a shareholder of Sequentify. L.S. and A.T. are shareholders of Cliseq. The other authors declare no competing interests.
